6-K: Report of foreign private issuer (related to financial reporting)

Jan 31 07:16 ET

20-F: FY2024 Annual Report

Jan 31 07:11 ET

6-K: Novartis Upgrades Mid-Term Guidance

Nov 25, 2024 10:22 ET

6-K: Financial Report Q3 2024

Oct 29, 2024 06:23 ET

6-K: Explanatory Note

Sep 18, 2024 16:42 ET

6-K: Novartis Second Quarter and Half Year 2024 Condensed Interim Financial Report – Supplementary Data

Jul 18, 2024 06:11 ET

6-K: Financial Report Q1 2024

Apr 23, 2024 06:09 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 31, 2024 07:46 ET

Novartis AG | 20-F: FY2023 Annual Report

Jan 31, 2024 07:41 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 24, 2023 06:33 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 5, 2023 06:10 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 21, 2023 06:05 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 18, 2023 07:30 ET

Novartis AG | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

May 15, 2023 16:40 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 25, 2023 07:30 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 1, 2023 07:53 ET

Novartis AG | 20-F: FY2022 Annual Report

Feb 1, 2023 07:46 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 25, 2022 09:40 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 25, 2022 08:58 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 19, 2022 06:49 ET